Collegium Pharmaceutical
COLL
158 hedge funds and large institutions have $898M invested in Collegium Pharmaceutical in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 61 increasing their positions, 43 reducing their positions, and 20 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 43
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less capital invested
Capital invested by funds: $900M → $898M (-$2.6M)
1.58% less ownership
Funds ownership: 109.35% → 107.77% (-1.6%)
3% less funds holding
Funds holding: 163 → 158 (-5)
15% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 20
88% less call options, than puts
Call options by funds: $2K | Put options by funds: $16K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Principal Financial Group
Des Moines,
Iowa
|
+$7.48M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$4.66M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.47M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$4.37M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$17.5M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
-$5.3M |
| 3 |
BlackRock
New York
|
-$5.08M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.16M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$2.92M |
COLL Hedge Fund Activity: Q2 2021 in Review
158 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q2 2021, worth a combined $898M — down 0.29% from $900M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of COLL and 17 opened new positions — a net loss of 3 holders — while 43 trimmed existing stakes and 61 added.
The largest buyer was Principal Financial Group, adding an estimated $7.48M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $17.5M sold.
- 158 institutional investors held Collegium Pharmaceutical (COLL) as of Q2 2021, down from 163 in Q1 2021.
- Funds reported $898M of Collegium Pharmaceutical stock for Q2 2021, down 0.29% quarter-over-quarter.
- 17 funds opened new Collegium Pharmaceutical positions in Q2 2021 and 20 closed out, a net change of -3 holders.
- The largest Collegium Pharmaceutical buyer in Q2 2021 was Principal Financial Group, an estimated $7.48M added.
- The largest Collegium Pharmaceutical seller in Q2 2021 was Avidity Partners Management, an estimated $17.5M sold.
Based on aggregated 13F filings for Q2 2021.